App aims to improve heart failure management through daily tracking
NCT ID NCT06750549
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a mobile app designed to help people with heart failure monitor their blood pressure, weight, and heart rate daily. The app also tracks symptoms and medications, sharing the data with doctors to guide treatment. Researchers wanted to see if using the app leads to better medication use and improved quality of life over 90 days. The study involved 134 participants recently hospitalized for heart failure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ENGAGE-HF mobile application (a device for self-monitoring and clinician feedback)
What this could lead to
If successful, this app could help heart failure patients better manage their condition and improve medication use and quality of life.
What could go wrong
This is a small, completed study (134 participants) testing a monitoring tool, not a treatment. Results may not apply to all heart failure patients, and the app itself does not directly treat the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford Cardiovascular Clinic
Stanford, California, 94305, United States
-
The Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
-
U-M Frankel Cardiovascular Center
Ann Arbor, Michigan, 48109, United States